Bone mineral density and related scores in Parkinson's disease: a systematic review and meta-analysis.

[1]  Jing Tian,et al.  Calcium supplementation for improving bone density in lactating women: a systematic review and meta-analysis of randomized controlled trials. , 2020, The American journal of clinical nutrition.

[2]  V. Povoroznyuk,et al.  Bone Mineral Density and Risk of Osteoporotic Fractures in Women with Parkinson's Disease , 2020, Journal of osteoporosis.

[3]  Qihang Sun,et al.  MPTP-Induced Impairment of Cardiovascular Function , 2020, Neurotoxicity Research.

[4]  C. Mao,et al.  Relationship between 25‐Hydroxyvitamin D, bone density, and Parkinson’s disease symptoms , 2019, Acta neurologica Scandinavica.

[5]  H. Terai,et al.  Surgical outcomes of spinal fusion for osteoporotic thoracolumbar vertebral fractures in patients with Parkinson’s disease: what is the impact of Parkinson’s disease on surgical outcome? , 2019, BMC Musculoskeletal Disorders.

[6]  V. Povoroznyuk,et al.  Bone Mineral Density, TBS, and Body Composition Indexes in Ukrainian Men with Parkinson's Disease , 2019, Parkinson's disease.

[7]  Alan H. Daniels,et al.  Etiology and Management of Spinal Deformity in Patients With Parkinson's Disease , 2018, International Journal of Spine Surgery.

[8]  Song Li,et al.  Biomarker Discovery in Parkinson’s Disease: Present Challenges and Future Opportunities , 2017, Neuroscience Bulletin.

[9]  Chun-Feng Liu,et al.  Clinical Significance of REM Sleep Behavior Disorders and Other Non-motor Symptoms of Parkinsonism , 2017, Neuroscience Bulletin.

[10]  Byeong-Chae Kim,et al.  The Association of Musculoskeletal Pain with Bone Mineral Density in Patients with Parkinson's Disease , 2017, European Neurology.

[11]  A. Çakcı,et al.  Bone mass and vitamin D levels in Parkinson’s disease: is there any difference between genders? , 2016, Journal of physical therapy science.

[12]  A. Tufekci,et al.  The relationship of vitamin D with bone mineral density in Parkinson's disease patients , 2016 .

[13]  Huimin Gao,et al.  Lower Bone Mineral Density in Patients with Parkinson’s Disease: A Cross-Sectional Study from Chinese Mainland , 2015, Front. Aging Neurosci..

[14]  V. Povoroznyuk,et al.  Bone mineral density in women with Parkinson's disease , 2015, Journal of the Neurological Sciences.

[15]  A. Lang,et al.  Parkinson's disease , 2015, The Lancet.

[16]  A. Yarnall,et al.  Occurrence, management and outcomes of hip fractures in patients with Parkinson's disease. , 2015, British medical bulletin.

[17]  A. Lees,et al.  Bone health in Parkinson's disease: a systematic review and meta-analysis , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  Li-Fang Hu,et al.  Elevated homocysteine levels in levodopa‐treated idiopathic Parkinson's disease: a meta‐analysis , 2013, Acta neurologica Scandinavica.

[19]  B. Bloem,et al.  Parkinson's disease and osteoporosis. , 2013, Age and ageing.

[20]  F. Backx,et al.  Bone mineral density and vitamin D status in Parkinson’s disease patients , 2013, Journal of Neurology.

[21]  Á. Gil,et al.  Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review , 2013, BMC Public Health.

[22]  A. LaCroix,et al.  Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). , 2012, Bone.

[23]  J. Woo,et al.  A case control study on bone mineral density in Chinese patients with Parkinson's disease. , 2010, Parkinsonism & related disorders.

[24]  A. Stang.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.

[25]  A. Abou-Raya,et al.  Bone and mineral metabolism in older adults with Parkinson's disease. , 2009, Age and ageing.

[26]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, BMJ : British Medical Journal.

[27]  Kwang-Soo Lee,et al.  The relationship between low bone mineral density and Parkinson’s disease in a Korean population , 2009, Journal of Clinical Neuroscience.

[28]  S. Carda,et al.  Osteoporosis in Parkinson's disease. , 2009, Parkinsonism & related disorders.

[29]  A. El Maghraoui,et al.  Prevalence and risk factors of osteoporosis in patients with Parkinson’s disease , 2008, Rheumatology International.

[30]  A. Kamanlı,et al.  Bone mineral density in patients with Parkinson’s Disease , 2008, Aging clinical and experimental research.

[31]  S. Cummings,et al.  The association of Parkinson’s disease with bone mineral density and fracture in older women , 2008, Osteoporosis International.

[32]  K. Ensrud,et al.  Association of Parkinson’s disease with accelerated bone loss, fractures and mortality in older men: the Osteoporotic Fractures in Men (MrOS) study , 2008, Osteoporosis International.

[33]  G. Toss,et al.  Bone mass in elderly patients with Parkinson’s disease , 2007, Acta neurologica Scandinavica.

[34]  F. Micheli,et al.  A pilot study on the impact of body composition on bone and mineral metabolism in Parkinson's disease. , 2007, Parkinsonism & related disorders.

[35]  M. Di Monaco,et al.  Bone mineral density in hip-fracture patients with Parkinson's disease: a case-control study. , 2006, Archives of physical medicine and rehabilitation.

[36]  C. Trenkwalder,et al.  Body weight in patients with Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[37]  B. Winblad,et al.  Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson's disease , 2006, Neuroscience Letters.

[38]  Hong-Hee Kim,et al.  Homocysteine Enhances Bone Resorption by Stimulation of Osteoclast Formation and Activity Through Increased Intracellular ROS Generation , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  R. Walker,et al.  Osteoporosis in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[40]  A. Zallone,et al.  Increased osteoclast activity in the presence of increased homocysteine concentrations. , 2005, Clinical chemistry.

[41]  J. Cauley,et al.  Association Between Parkinson's Disease and Low Bone Density and Falls in Older Men: The Osteoporotic Fractures in Men Study , 2005, Journal of the American Geriatrics Society.

[42]  Yoshihiro Sato,et al.  High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease [RETRACTED] , 1997, Neurology.

[43]  V. Crawford,et al.  Reduced bone density of the hip in elderly patients with Parkinson's disease. , 1995, Age and ageing.

[44]  K. Khaw,et al.  Body composition and bone mass in post‐menopausal women , 1992, Clinical endocrinology.

[45]  J. Iwamoto,et al.  Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in Parkinson's disease. , 2011, Parkinsonism & related disorders.

[46]  J. Kanis,et al.  INTERNATIONAL OSTEOPOROSIS FOUNDATION. AN UPDATE ON THE DIAGNOSIS AND ASSESSMENT OF OSTEOPOROSIS WITH DENSITOMETRY , 2000 .

[47]  R. Monie,et al.  Occasional Review , 2022 .